Here's a roundup of top developments in the biotech space over the last 24 hours:Stocks In FocusUS Government Calls For Additional Doses Of Pfizer/BioNTech COVID-19 Vaccine...
Here's a roundup of top developments in the biotech space over the last 24 hours:Stocks In FocusUS Government Calls For Additional Doses Of Pfizer/BioNTech COVID-19...
The FDA has placed Sanofi (EPA:SASY) SA's (NASDAQ: SNY) Phase 3 studies of tolebrutinib in multiple sclerosis and myasthenia gravis on partial clinical hold. New enrollment in the...
Immunocore announces clinical trial collaboration with Sanofi to evaluate Sanofi’s product candidate SAR444245, non-alpha IL-2, in combination with KIMMTRAK® in patients with...
Traders await US economic data to justify strongest monthly stock advance in 3 decadesOil rebound slowsBitcoin close to all-time highKey EventsThe most powerful global, monthly...
European equities opened firmer again on Thursday morning, extending gains from a very strong session on Wall Street. France’s CAC led the way after President Macron announced an...
Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Sell | Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Sell | Sell | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Sell | Sell | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 19.66 | 21.70 | 19.27 | -1.34 | -6.36% | 6.12M | London | |||
| 24.80 | 24.80 | 24.80 | 0.00 | 0.00% | 20.00 | London | |||
| 55.48 | 56.82 | 55.00 | -0.68 | -1.21% | 4.34M | London | |||
| 295.00 | 297.00 | 275.00 | +18.00 | +6.50% | 1.34M | London | |||
| 128.66 | 130.48 | 128.30 | +1.30 | +1.02% | 34.99M | London | |||
| 192.55 | 194.40 | 191.65 | +0.35 | +0.18% | 4.15M | London | |||
| 55.00 | 57.00 | 54.60 | +1.10 | +2.04% | 114.51K | London | |||
| 114.70 | 119.20 | 113.80 | -2.95 | -2.51% | 3.35M | London | |||
| 405.00 | 405.50 | 403.00 | +4.00 | +1.00% | 554.71K | London | |||
| 57.10 | 57.70 | 55.90 | +0.60 | +1.06% | 2.99M | London | |||
| 317.80 | 323.60 | 317.20 | -0.20 | -0.06% | 324.93K | London | |||
| 1,076.50 | 1,079.00 | 1,072.00 | +4.50 | +0.42% | 3.50M | London | |||
| 110.80 | 113.30 | 109.80 | -1.00 | -0.89% | 10.12M | London | |||
| 891.00 | 894.50 | 861.00 | +9.0 | +1.02% | 612.83K | London | |||
| 2,228.00 | 2,258.00 | 2,216.00 | -6.0 | -0.27% | 279.75K | London |